Method for improving activity of gene knockout and base editing system by using small molecule compound and application method thereof
A small molecule compound and gene knockout technology, applied in the field of genetic engineering, can solve the problems of low activity of precise site-specific gene editing, low efficiency of gene knockout and base editing system, etc., and achieve the effect of high gene editing efficiency
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Publication Date
- 2021-08-06
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of genetic engineering, and relates to a method for improving the activity of a gene knockout and base editing system and an application method thereof. Background technique
[0002] Gene editing technology refers to the use of nucleases to directly edit DNA sequences to achieve knockout, insertion / deletion or replacement of specific DNA fragments. At present, the development and transformation of gene editing tools has always been the research focus of scientists in the field of life sciences in the 21st century, and new gene editing tools are emerging in an endless stream. Clustered regular interspaced short palindromic repeats (CRISPR) / CRISPR-associated Protien 9 (Cas9) is the next step of zinc finger nuclease (ZFN) and transcriptional activator A new generation of genetic modification tools following transcription activator-like effector nucleases (TALEN) technology, this CRISPR / Cas9 editing system uses single-st...
Examples
Embodiment 1
[0049] Embodiment 1: Construction of px330-CBE expression vector
[0050] (1) Experimental materials include:
[0051] Primers, restriction endonucleases, plasmid recombination kits, plasmid extraction kits, gel recovery kits, high-fidelity DNA polymerase, and genomic DNA extraction kits according to conventional methods. The plasmid pZHW-PBE contains the CBE sequence: SEQ ID NO.1. Plasmid px330, plasmid pCMV-ABEmax, plasmid pJET-U6. Plasmid pJET-U6 is the backbone of pJET1.2 (CloneJETPCR Cloning Kit, Thermo Fisher Scientific) connected with U6 and scaffold fragments (see SEQ ID NO.2 for the fragment sequence). Transfection Reagent Turbofect and T4 DNA Ligase.
[0052] Specifically, SEQ ID NO.2 U6-scaffold sequence
[0053] gagggcctatttcccatgattccttcatatttgcatatacgatacaaggctgttagagagataattggaattaatttgactgtaaacacaaagatattagtacaaaatacgtgacgtagaaagtaataatttcttgggtagtttgcagttttaaaattatgttttaaaatggactatcatatgcttaccgtaacttgaaagtatttcgatttcttggctttatatatcttgtggaaaggacgaaacaccgggt...
Embodiment 2
[0068] Embodiment 2: the establishment of the BFP reporter system that is used for CBE activity test
[0069] (1) Construct the px330-AAVS1 vector, which contains the sgRNA targeting the AAVS1 site (see Table 1 for the sequences AAVS1-sgRNA-F and AAVS1-sgRNA-R). Construct a vector (pdonor-BFP-IRES-PURO) expressing BFP with a homology arm of AAVS1 site, which contains AAVS1 homology arm, blue fluorescent protein (BFP), IRES and puromycin (Puromycin) resistance gene .
[0070] (2) Recovery of HEK-293 cells: Take out the tube of cryopreserved HEK-293 cells from liquid nitrogen, immediately put it into a 37°C water bath, shake slightly, and wait until the liquid is completely melted (about 1-1.5min), 1000rpm , and centrifuged for 3min; take it out and wipe it with 75% alcohol and put it on the ultra-clean workbench; discard the supernatant, add 1ml of cell culture medium to resuspend the cells, and then transfer to a 10cm culture dish containing 10ml of culture medium. Shake gen...
Embodiment 5
[0090] Example 5: Establishment of HEK293-ABCA4 cell line
[0091] (1) Construction of recombinant vector pdonor-ABCA4:
[0092] The partial sequence of the mutant ABCA4 gene (as shown in 4) was amplified by PCR and cloned into the vector pdonor-BFP-IRES-PURO to obtain the recombinant pdonor-ABCA4 vector.
[0093] (2) Construction of a monoclonal HEK293 cell line integrated with the mutant ABCA4 gene:
[0094] Step 1: HEK293 cells were seeded in a 12-well plate after counting, and the cell density in each well was 1.6×10 5 cells / well;
[0095] Step 2: Cell transfection was carried out after 24 hours. The experimental group was co-transfected with px330-AAVS1 and pdonor-ABCA4 vectors, and the negative control group was co-transfected with px330 and pdonor-ABCA4 vectors. The rest of the conditions were the same as those of the experimental group;
[0096] Step 3: Change the medium 24 hours after transfection, and transfer to a 10cm dish after 48 hours;
[0097] Step 4: After...